Skip to nav Skip to content

CDC/IDSA COVID-19 Clinician Call: The Johnson & Johnson Vaccine: Current Situation & Anticipated Next Steps

Facebook Twitter LinkedIn Email

To Download a copy of the presentation click here.

*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.

Moderator:

Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA

Topics and Featured Experts:

The Johnson & Johnson Vaccine: Current Situation & Anticipated Next Steps

• Tom Shimabukuro, MD, MPH, MBA
Captain, U.S. Public Health Service
Deputy Director
Immunization Safety Office
Centers for Disease Control and Prevention

• Sara Oliver, MD, MSPH
LCDR, U.S. Public Health Service
Co-Lead, COVID-19 Work Group of the Advisory Committee on Immunization Practices
Centers for Disease Control and Prevention

• Michael B. Streiff, MD
Medical Director
The Johns Hopkins Anticoagulation Management Service and Hemostatic Disorder Stewardship Program
Johns Hopkins Special Coagulation Laboratory
Professor of Medicine & Professor of Pathology
Johns Hopkins University School of Medicine

• John Su, MD, PhD, MPH
VAERS Team Lead
Centers for Disease Control and Prevention

Latest Media

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.